A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in comparison with carotid endarterectomy (CEA) is being launched by the Society for Vascular Surgery Patient Safety Organization (SVS PSO). Carotid artery stenting (CAS) and CEA are performed in patients with atherosclerotic narrowing of the carotid artery in order to reduce stroke risk.
SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical Device, which is approved and CE Marked in Europe for left atrial appendage (LAA) closure. Krzysztof Bartus, M.D., Ph.D., and associate professor of the Jagiellonian University, Department of Cardiovascular and Transplant Surgery in Krakow, Poland performed the procedures.
The U.S. Food and Drug Administration (FDA) changed its rules concerning custom medical devices Oct. 12, adding new ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical trial results at VIVA 16, hosted at the Wynn Las Vegas Sept. 18-22.
October 12, 2016 — The Society for Vascular Surgery (SVS) has released new reporting standards focused on endovascular ...
While guidewires are a key tool used by all interventionalists in the cath lab, most operators do not have a deep ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Medtronic plc announced recently that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer angled support catheter for use in the peripheral vascular system. Support catheters such as the Trailblazer are often used in endovascular procedures treating complex peripheral artery disease (PAD).
Awards from the National Institutes of Health’s Common Fund are supporting research on the peripheral nervous system, in hopes of finding new ways to treat conditions such as asthma, diabetes and nausea. The new awards total more than $20 million in fiscal year 2016, and go to 27 multidisciplinary research teams through the Stimulating Peripheral Activity to Relieve Conditions (SPARC) program. The SPARC program plans to support awards totaling approximately $238M through fiscal year 2021, pending available funds.
The U.S. Food and Drug Administration (FDA) has issued 510(K) Class II clearance to a web client for the AirStrip One mobile interoperability platform and application. The system can be run on desktops and laptops using Internet Explorer and Google Chrome.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 10, 2016 — ZipLine Medical Inc. recently announced results from a study recently published online in Pacing and ...
Francesco Maisano, clinic director at the University Hospital Zurich, recently led a team of cardiac surgeons and cardiologists in for the first time repairing a leaky tricuspid valve using a new catheter technology.
St. Jude Medical Inc. announced the U.S. clearance and launch of the company’s new PressureWire X Guidewire fractional flow reserve (FFR) measurement system. The latest generation of the PressureWire Guidewire system is designed to offer improved shapeability and better shape retention aimed at reducing vessel trauma, with the accuracy and simplicity physicians expect when treating patients during percutaneous coronary intervention (PCI), especially those with complex anatomies.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The transradial revolution is one of the fastest growing trends in cardiology. Compared to the femoral access technique ...
Mercator MedSystems recently announced that 13-month data from the DANCE trial was presented during a late-breaking scientific session at the Vascular Interventional Advances (VIVA) Annual Conference 2016. DANCE is a prospective, multicenter, single-arm study designed to assess the clinical performance of the localized delivery of a generic steroid, dexamethasone, to the tissues around arteries that have been injured during endovascular interventions, using Mercator’s proprietary Bullfrog Micro-Infusion Device.
October 7, 2016 — A Northwestern Medicine cardiac surgeon was recently the first in Illinois and second in the United ...
October 13, 2016
